National Institute of Justice May 2013; Award Number: 2008-DN-BX-K144
Acquiring a DNA profile from large volume highly degraded or compromised forensic samples is particularly challenging sample type to be interfaced with a microfluidic system. Previous microfluidic devices utilizing a silica-based solid phase have been successful at purifying DNA from complex biological samples such as whole blood, however due to their small cross-sectional areas cannot operate at fast enough flow rates to make the processing of mL volumes a feasible option. The development of a volume reduction solid phase extraction (vrSPE) device employs a large cross-sectional area, enabling flow rates capable of handling a 0.5 mL sample in just ~30 minutes was realized. The large solid phase allows for greater binding sites on the silica surface, capable of binding the DNA but also the binding of PCR inhibitors, removing them from the eluate allowing for successful DNA profiling. In addition the vrSPE device reduces, and thus concentrates the DNA found in large volume samples often encountered throughout an investigation. Such samples include whole blood and semen stains, which need to be solubilized from the substrate prior to processing, diluting the DNA to concentrations in the order of 0.1 ng/μL. The vrSPE device was utilized to purify degraded whole blood and semen stains that were exposed up to 80°C for three months or subjected to UV light for the equivalent of 8 months and 16 days in LA sunlight, resulting in full STR profiles in each instance.
The extraction of bone was also demonstrated, a particularly difficult sample type due to the demoralization of the bone; a partial profile of 15 of 16 loci was produced. Once nuclear DNA is too degraded for STR amplification, mitochondrial DNA (mtDNA) can be used to identify persons. mtDNA is particularly susceptible to contamination, therefore an especially suitable sample type for the closed system microfluidic platform. The vrSPE device successfully purified and extracted amplifiable mtDNA from a severely heat degraded whole blood stain. The solid phase was also demonstrated to effectively remove inhibitors from the sample, specifically 35 μg of humic acid which is found in soil, outperforming current methods which see allelic dropout at 27 μg. The addition of a downstream μSPE phase, using chitosan-coated silica particles providing completely aqueous chemistry, further enhanced the removal of indigo dye – a common sample
contaminant found in blue jeans. STR profiles produced with the dual phase device were superior to those from the vrSPE channel alone, whereas a single μSPE channel failed to produce any peaks. This second phase offers two key advantages over one vrSPE alone – further removal of inhibitory material and increased concentration of the sample, especially resonant with severely diluted samples. Once the vrSPE method was fully established and demonstrated to be applicable to a plethora of sample types, fabrication of further devices in either a multi-channel or multiplex format were devised. For ease of fabrication and increased reproducibility between multiple channels, poly (methyl methacrylate) PMMA, was chosen as the new substrate for these devices. Following verification that PMMA operated as well as the previous glass substrate devices, a multiplex extraction of four separate dilute whole blood samples from four individuals was performed, resulting in full STR profiles. These results show the vrSPE technology is a successful method for processing a wide variety of large volume, degraded, inhibited biological samples in a timely, cross-contamination free manner.
If link does not work, request the report from Information & Research Services (QH Staff only)